FEAR & GREED | Business News

It's been another strong year for superannuation returns, but not without plenty of surprises.

Sean Aylmer speaks with Jonathan Armitage, Chief Investment Officer at Colonial First State, about the investment themes that shaped the financial year and how investors can look at the next twelve months, from emerging markets to AI.

This is general information only. You should seek professional advice tailored to your circumstances before making investment decisions.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.

This is the Fear & Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes.
ASX off 0.6pc

Govt open to regulating accounting firms

Building approvals fall

Karl Stefanovic dropped from radio show

Trump’s setback in US Supreme Court

We’re running a short survey to hear from you, with the team at Fonto. It only takes a few minutes, and you can be in the running to win a $3,000 Luxury Escapes voucher.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.

Wednesday 1 July 2026
The financial year ends with the ASX200 finishing less than three per cent higher, with big gains from miners offset by losses in tech and healthcare stocks.
The ACCC sues Amazon Prime over the cost of subscriptions
Two EY graduates sacked after accessing the PM’s personal details
The ATO says doing your tax return quickly, doesn’t mean you’ll get a fast refund
The biopic film Michael, about pop star Michael Jackson, leads a Hollywood revival

Hit follow on the podcast so you don’t miss the latest news, and join our free daily newsletter here

And don’t miss the latest episode of How Do They Afford That? - six goals for the new financial year. Get the episode from Apple, Spotify or anywhere you listen to podcasts.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.

Most Australians first heard about RNA during the COVID pandemic. But scientists believe that was only the beginning.

Sean Aylmer speaks with Paul McDonald, CEO of RNA Australia, about the technology that's already transforming medicine and could soon play a major role in treating cancer, rare diseases, respiratory illnesses and biosecurity threats. McDonald explains how RNA therapies work, why Australia has traditionally struggled to commercialise world-class research, and how a new end-to-end RNA manufacturing facility aims to keep Australian discoveries in Australia.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.

This is the Fear & Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes.
ASX down for day, up for year

Businesses report jump in expenses

Corporate wrap: Collins Foods, Atlas Arteria, Neuren

AGL worker ordered to attend office

Trump’s big day in US Supreme Court

We’re running a short survey to hear from you, with the team at Fonto. It only takes a few minutes, and you can be in the running to win a $3,000 Luxury Escapes voucher.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.